Intervention

basal insulin

ClinicalTrials.gov intervention label

Clinical trials8
Recruiting0
Common conditions5
Lead sponsors shown5

Clinical trials

8 shown
Impact of GLP-1 RAs Compared to Basal Insulin Start in Patients Living With Type 2 Diabetes and Chronic Kidney DiseaseNCT06236672 · 2023-02-15
COMPLETED
Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During RamadanNCT02941367 · 2017-02-23
COMPLETED
Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy?NCT02846233 · 2016-08-01
COMPLETED
Subanalyses of Elderly Type 2 Diabetes Patients or Type 2 Diabetes Patients With Renal ImpairmentNCT02917057 · 2015-08-01
COMPLETED
Clinical Outcomes of Exenatide Versus Basal InsulinNCT02987348 · 2015-06-30
COMPLETED
Comparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal InsulinsNCT02974244 · 2014-10-28
COMPLETED
Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 DiabetesNCT01850615 · 2013-09-23
COMPLETED
Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 DiabetesNCT01060059 · 2010-04-01
COMPLETED

Trial status mix

COMPLETED8

Phase mix

NA1
PHASE31
PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.